Jacob Orville's most recent trade in Exact Sciences Corp. was a trade of 4,948 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,948 | 14,845 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,948 | 27,728 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,725 | 25,001 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,725 | 9,450 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. | 28 Feb 2025 | 2,326 | 25,402 (0%) | 0% | 47.8 | 111,229 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. | 28 Feb 2025 | 2,221 | 22,780 (0%) | 0% | 47.8 | 106,208 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 28,779 | 28,779 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 3,954 | 3,955 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 3,954 | 22,136 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. | 24 Feb 2025 | 1,859 | 20,277 (0%) | 0% | 51.3 | 95,330 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,805 | 20,407 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 2,248 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 2,248 | 16,688 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.48 per share. | 19 Feb 2025 | 2,225 | 18,182 (0%) | 0% | 50.5 | 112,318 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. | 19 Feb 2025 | 1,086 | 15,602 (0%) | 0% | 49.6 | 53,898 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | EVP, GM, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 21,401 | 21,401 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 218 | 14,542 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 30 Apr 2024 | 102 | 14,440 (0%) | 0% | 60.1 | 6,135 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 4,724 | 16,478 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 4,724 | 14,175 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Sale of securities on an exchange or to another person at price $ 59.32 per share. | 29 Feb 2024 | 2,154 | 14,324 (0%) | 0% | 59.3 | 127,775 | Common Stock |
| Exact Sciences Corp. | Orville Jacob | General Manager, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 19,793 | 19,793 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 3,954 | 7,909 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 3,954 | 13,633 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Orville Jacob | General Manager, Screening | Sale of securities on an exchange or to another person at price $ 56.89 per share. | 26 Feb 2024 | 1,879 | 11,754 (0%) | 0% | 56.9 | 106,896 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 2,034 | 10,692 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Orville Jacob | General Manager, Screening | Sale of securities on an exchange or to another person at price $ 59.78 per share. | 21 Feb 2024 | 1,013 | 9,679 (0%) | 0% | 59.8 | 60,557 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,248 | 9,736 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 2,248 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Orville Jacob | General Manager, Screening | Sale of securities on an exchange or to another person at price $ 61.50 per share. | 20 Feb 2024 | 1,078 | 8,658 (0%) | 0% | 61.5 | 66,297 | Common Stock |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 2,031 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jacob Orville | General Manager, Screening | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 2,031 | 8,454 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Orville Jacob | General Manager, Screening | Sale of securities on an exchange or to another person at price $ 61.43 per share. | 14 Feb 2024 | 966 | 7,488 (0%) | 0% | 61.4 | 59,341 | Common Stock |